#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Hemophilia

We recommend kloub

Evaluation of Joint Condition in Daily Practice in the Era of New Hemophilia Treatment

10. 6. 2024 Source: Hemophilia

With the development of new treatment options for hemophilia, there has also been progress in methods for monitoring hemophilic arthropathy and identifying it in its early stages. In addition to classical X-rays, clinical scoring systems, and the gold standard of magnetic resonance imaging (MRI), the so-called POCUS – point-of-care ultrasound – has emerged as a quick and reliable method for assessing joint health. Potential biomarkers for osteochondral damage and synovial proliferation specific to hemophilia or for detecting joint…

hemofilie

Collagen Turnover as a Biomarker of Hemophilia Treatment Efficacy

Over the past decades, hemophilia treatment has made significant progress—from factor therapy to…
10. 6. 2024 Source: Hemophilia
krev_zkumavky

FEIBA in Real Clinical Practice – Fresh Data from the Observational Study FEIBA GO

FEIBA GO (Global Outcome) was a prospective observational study evaluating the long-term…
27. 11. 2023 Source: Hemophilia

Articles on this topic
ilustrační foto v tiskové kvalitě L 2356 x 1571

Observational Study of Pegylated rVIII Administration in Real Clinical Practice

A recently published article by American hematologists provided valuable information about the…
21. 9. 2020 Source: Hemophilia

Cost-effectiveness in Bleeding Control for Acquired Hemophilia A

A pharmacoeconomic analysis showed favorable cost-effectiveness of activated prothrombin…
18. 9. 2020 Source: Hemophilia
boty_nohy_chůze_běh_pohyb_sport_muž_procházka

Minimum and Optimal Factor Levels in Physically Active Hemophiliacs

Authors of a recently published study attempted to determine the value of minimum and optimal…
2. 7. 2020 Source: Hemophilia
hemofilie_zkumavky

Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy

New molecules in hemophilia therapy have raised many questions, including regarding the…
18. 3. 2020 Source: Hemophilia

Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia

Experience shows that monitoring joint changes, especially subclinical ones, is very necessary…
16. 3. 2020 Source: Hemophilia

Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A

With new treatment options for hemophilia A without inhibitors, the question of…
15. 1. 2020 Source: Hemophilia
rodina_muzi_dedecek_syn_vnuk

Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?

The aging population of individuals with hemophilia brings new experiences and challenges,…
10. 1. 2020 Source: Hemophilia

1 2 3 4
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#